Fig. 7From: Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinomaComparison of drug sensitivities in the high- and low-IRGS groups. The estimated IC50s of Bortezomib, Cisplatin, Cyclopamine, Docetaxel, Epothilone.B, Paclitaxel, Parthenolide, Pazopanib in the high- and low-IRGS groups in the TCGA (A), GSE68465 (B), GSE72094 (C) cohortsBack to article page